Attrition and its consequences in a clinical trial of placebo, imipramine, and phenelzine.
D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D010349:Patient Compliance; D010352:Patient Dropouts
D007099:Imipramine